Deborah Baron to Anti-HIV Agents
This is a "connection" page, showing publications Deborah Baron has written about Anti-HIV Agents.
Connection Strength
0,673
-
Applying CFIR to assess multi-level barriers to PrEP delivery in rural South Africa: Processes, gaps and opportunities for service delivery of current and future PrEP modalities. Soc Sci Med. 2024 Nov; 361:117370.
Score: 0,125
-
Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial. AIDS Behav. 2022 Dec; 26(12):3950-3962.
Score: 0,107
-
"You talk about problems until you feel free": South African adolescent girls' and young women's narratives on the value of HIV prevention peer support clubs. BMC Public Health. 2020 Jun 26; 20(1):1016.
Score: 0,093
-
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial. J Int AIDS Soc. 2020 05; 23(5):e25491.
Score: 0,092
-
Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project. Cult Health Sex. 2021 02; 23(2):257-272.
Score: 0,091
-
"It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis. AIDS Behav. 2018 Nov; 22(11):3692-3704.
Score: 0,083
-
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
Score: 0,083